FGFR2 and breast cancer: Genome-Wide-Association-Studies (GWAS) have shown that SNPs in the second intron of the FGFR2 gene are significantly associated with high risk of breast cancer, in particular in post-menopausal women [105,203–205], confirming an oncogenic role for FGFR2.